top of page
New Evidence in First-Line AML & Exploring Outcomes with Fixed-Duration Treatment in CLL
Tue, Nov 17
|Webinar
Registration is Closed
See other events
Time & Location
Nov 17, 2020, 6:00 PM
Webinar
About The Event
Tuesday, November 17, 2020, 6:00 PM ET
Thomas LeBlanc, MD, MA, MSH, FAAHPM Associate Professor, Division of Hematologic Malignancies and Cellular Therapy Department of Medicine, Duke University, Durham, NC
Nakhle Saba, MD Associate Professor of Medicine, Section of Hematology and Medical Oncology Tulane University, New Orleans, LA
REGISTER via link below:
https:// abbvie.meintl.com/00071-OB22-20
DURING THIS INTERACTIVE PROGRAM WE WILL:
bottom of page